Group 1 - The Hang Seng Index rose by 2%, reaching a new high since 2021, while the Hang Seng Tech Index increased by over 3.06% [1] - The Hong Kong Stock Connect saw a net inflow of HKD 5.16 billion last Friday, with continued net buying of over HKD 900 million in the morning session [1] - Major companies like China Telecom, JD Logistics, and Pop Mart were included in the Hang Seng Index's quarterly review [1] Group 2 - Haitong International noted that Hong Kong tech companies are becoming more competitive in the AI sector, with leading firms increasing their capital expenditure in AI [2] - The potential for foreign capital inflow in Hong Kong stocks may exceed expectations due to the Federal Reserve's potential interest rate cuts [2]

国金证券认为，医药板块中最值得关注的是创新药赛道，对创新医药投资机会的把握将是贯穿2025年全 年医药投资的主线。创新药龙头商业销售和BD业绩持续兑现，随着临床推进和数据读出，中国创新药 企业在肿瘤、自免及慢病领域潜力大单品预期增强，给细分赛道领先公司的成长空间和估值修复提供支 撑。全球领先的创新品种进入业绩放量兑现期，国际领先的临床突破或BD不断涌现。 相关产品：恒生生物科技ETF(159615)；香港科技ETF(159747)；恒生指数ETF(513600)；H股 ETF(159954)；更多相关场外基金——南方恒生科技指数发起（A类：020988；C类：020989）助力投资 者把握港股市场投资机遇。 2025年5月20日，恒生生物科技ETF(159615)盘初强势拉升，涨超4%，冲击3连涨。截至09:53，盘中换 手14.78%，成交4890.55万元，市场交投活跃。跟踪指数恒生生物科技指数强势上涨3.14%，成分股三生 制药上涨29.93%，荣昌生物上涨7.29%，诺诚健华上涨5.88%，石药集团，泰格医药等个股跟涨。 消息面上，恒生生物科技ETF(159615)成分股——三生制药今日早盘高开高走一 ...

Group 1 - The Hong Kong stock market is experiencing an upward trend, with technology stocks performing strongly, as evidenced by the Hong Kong Technology ETF (159747) rising nearly 2% [1] - The market is active, with a trading volume of 88.77 million yuan and a turnover rate of 23.4% for the Hong Kong Technology ETF [1] - The CSI Hong Kong Technology Index has increased by 1.24%, with notable gains in individual stocks such as 3SBio (up 5.39%), Kingdee International (up 4.76%), and Li Auto (up 4.64%) [1] Group 2 - Guoyuan International Holdings suggests that the Hong Kong stock market may continue to digest previous valuation increases, with upcoming earnings reports set to validate market expectations regarding AI's impact [1] - CITIC Securities highlights that core assets in the new economy, characterized by high consensus and large capacity, are uniquely positioned in the Hong Kong market, focusing on four key sectors: domestic computing power, internet, smart vehicles, and innovative pharmaceuticals [1] - Many companies in the Hong Kong market are still in the early stages of recovering net profit margins and revenue growth, indicating significant potential for improvement in profitability as the economy rebounds [1]